name: scientific-manuscript
description: "High-impact scientific manuscript preparation for journals like Nature, Blood, Cell. Use when writing abstracts, introductions, methods, results, discussions, or figure legends. Includes citation management, statistical reporting standards, ICMJE guidelines, and journal-specific formatting for hematology/oncology publications."
license: Proprietary
Scientific Manuscript Preparation
Document Structure for High-Impact Journals
Title
- Concise (<15 words for Nature, <20 for Blood)
- Include key finding and system/disease
- Avoid jargon and abbreviations
Abstract (Structured for Blood/Clinical Journals)
**Background:** One sentence on knowledge gap.
**Methods:** Key approaches, patient cohort size, techniques.
**Results:** Primary findings with statistics (P values, CIs).
**Conclusions:** Clinical/translational significance.
Introduction (~500-800 words)
- Paragraph 1: Broad context, disease burden, clinical relevance
- Paragraph 2: Current knowledge, key mechanisms
- Paragraph 3: Knowledge gap, unanswered questions
- Paragraph 4: Study aims, hypothesis, approach overview
Methods (Detailed, Reproducible)
**Patient Cohort and Samples**
- IRB approval number, consent process
- Inclusion/exclusion criteria
- Sample processing, storage conditions
**Single-Cell RNA Sequencing**
- Library preparation (10x Genomics Chromium 3' v3.1)
- Sequencing platform, read depth
- Quality metrics (cells/sample, genes/cell, % mitochondrial)
**Computational Analysis**
- Software versions (Scanpy 1.9.x, scvi-tools 0.20.x)
- QC thresholds (min genes, max %MT)
- Integration method (TotalVI, Harmony)
- Clustering parameters (resolution, n_neighbors)
- Differential expression (Wilcoxon, FDR < 0.05, |log2FC| > 1)
**Statistical Analysis**
- Software (R 4.3.x, Python 3.11)
- Tests used with justification
- Multiple testing correction method
- Power analysis if applicable
Results (~2000-3000 words)
- Lead each paragraph with key finding
- Reference figures in order (Figure 1A-C...)
- Report exact P values (P = 0.003, not P < 0.05)
- Include confidence intervals where relevant
- Avoid interpretation; save for Discussion
Discussion (~1500-2000 words)
**Paragraph 1**: Summarize key findings, relate to hypothesis
**Paragraph 2-4**: Compare to existing literature
- "Consistent with [Author et al.], we found..."
- "In contrast to [Study], our analysis revealed..."
- Mechanistic interpretation
**Paragraph 5**: Translational/Clinical implications
- Therapeutic targets
- Biomarkers
- Patient stratification
**Paragraph 6**: Limitations
- Sample size, cohort characteristics
- Technical limitations
- Generalizability
**Paragraph 7**: Future directions and conclusion
Statistical Reporting Standards
Continuous Variables
- Mean ± SD (normal) or Median [IQR] (non-normal)
- Report normality test used
Categorical Variables
- N (%) with comparison test
P Values
- Report exact values (P = 0.023)
- For very small: P < 0.0001
- Always report test used
Sample Sizes
- "n = X patients" or "n = X cells"
- Report for each comparison group
Figure Legends Template
**Figure 1. Title describes main finding**
(A) Brief description of panel A. Statistical test, P value.
(B) Description including axis labels if not obvious.
(C-D) Can combine similar panels.
Scale bars: X μm. Error bars: mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
n = X biological replicates from Y independent experiments.
Reference Formatting
Blood Journal (Vancouver)
1. Smith JA, Jones BC. Title of article. Blood. 2024;143(5):567-578.
Nature (Author-Year)
Smith, J.A. & Jones, B.C. Title of article. Nature 620, 567–578 (2024).
Journal-Specific Requirements
Blood (ASH)
- Word limit: 4000 (full article)
- Figures: 7 max
- References: 60 max
- Structured abstract: 250 words
Nature
- Word limit: ~3000 (Article)
- Main text figures: 6-8
- Methods: no limit, separate section
- Extended Data for supplementary figures
Cell
- Word limit: 7000 (Article)
- STAR Methods format
- Graphical abstract required
HIPAA Compliance Reminders
- No patient identifiers in any form
- Use Specimen IDs, not patient names/MRNs
- Aggregate data for small groups (n < 5)
- IRB approval statement required
- Data availability statement (GEO accession for sequencing)
Writing Style
- Active voice preferred
- Past tense for results ("We found...")
- Present tense for established facts
- Avoid "interesting," "significant" (unless statistical)
- Be specific: "83.9-fold increase" not "marked increase"
See references/journal_templates.md for specific formats.
See references/statistical_tests.md for test selection guide.
1---2name: scientific-manuscript3description: <!--4---5<!--6# COPYRIGHT NOTICE7# This file is part of the "Universal Biomedical Skills" project.8# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>9# All Rights Reserved.10#11# This code is proprietary and confidential.12# Unauthorized copying of this file, via any medium is strictly prohibited.13#14# Provenance: Authenticated by MD BABU MIA1516-->1718---19name: scientific-manuscript20description: "High-impact scientific manuscript preparation for journals like Nature, Blood, Cell. Use when writing abstracts, introductions, methods, results, discussions, or figure legends. Includes citation management, statistical reporting standards, ICMJE guidelines, and journal-specific formatting for hematology/oncology publications."21license: Proprietary22---2324# Scientific Manuscript Preparation2526## Document Structure for High-Impact Journals2728### Title29- Concise (<15 words for Nature, <20 for Blood)30- Include key finding and system/disease31- Avoid jargon and abbreviations3233### Abstract (Structured for Blood/Clinical Journals)3435```markdown36**Background:** One sentence on knowledge gap.37**Methods:** Key approaches, patient cohort size, techniques.38**Results:** Primary findings with statistics (P values, CIs).39**Conclusions:** Clinical/translational significance.40```4142### Introduction (~500-800 words)431. **Paragraph 1**: Broad context, disease burden, clinical relevance442. **Paragraph 2**: Current knowledge, key mechanisms453. **Paragraph 3**: Knowledge gap, unanswered questions464. **Paragraph 4**: Study aims, hypothesis, approach overview4748### Methods (Detailed, Reproducible)4950```markdown51**Patient Cohort and Samples**52- IRB approval number, consent process53- Inclusion/exclusion criteria54- Sample processing, storage conditions5556**Single-Cell RNA Sequencing**57- Library preparation (10x Genomics Chromium 3' v3.1)58- Sequencing platform, read depth59- Quality metrics (cells/sample, genes/cell, % mitochondrial)6061**Computational Analysis**62- Software versions (Scanpy 1.9.x, scvi-tools 0.20.x)63- QC thresholds (min genes, max %MT)64- Integration method (TotalVI, Harmony)65- Clustering parameters (resolution, n_neighbors)66- Differential expression (Wilcoxon, FDR < 0.05, |log2FC| > 1)6768**Statistical Analysis**69- Software (R 4.3.x, Python 3.11)70- Tests used with justification71- Multiple testing correction method72- Power analysis if applicable73```7475### Results (~2000-3000 words)76- Lead each paragraph with key finding77- Reference figures in order (Figure 1A-C...)78- Report exact P values (P = 0.003, not P < 0.05)79- Include confidence intervals where relevant80- Avoid interpretation; save for Discussion8182### Discussion (~1500-2000 words)8384```markdown85**Paragraph 1**: Summarize key findings, relate to hypothesis8687**Paragraph 2-4**: Compare to existing literature88- "Consistent with [Author et al.], we found..."89- "In contrast to [Study], our analysis revealed..."90- Mechanistic interpretation9192**Paragraph 5**: Translational/Clinical implications93- Therapeutic targets94- Biomarkers95- Patient stratification9697**Paragraph 6**: Limitations98- Sample size, cohort characteristics99- Technical limitations100- Generalizability101102**Paragraph 7**: Future directions and conclusion103```104105## Statistical Reporting Standards106107### Continuous Variables108- Mean ± SD (normal) or Median [IQR] (non-normal)109- Report normality test used110111### Categorical Variables112- N (%) with comparison test113114### P Values115- Report exact values (P = 0.023)116- For very small: P < 0.0001117- Always report test used118119### Sample Sizes120- "n = X patients" or "n = X cells"121- Report for each comparison group122123## Figure Legends Template124125```markdown126**Figure 1. Title describes main finding**127(A) Brief description of panel A. Statistical test, P value.128(B) Description including axis labels if not obvious.129(C-D) Can combine similar panels.130Scale bars: X μm. Error bars: mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.131n = X biological replicates from Y independent experiments.132```133134## Reference Formatting135136### Blood Journal (Vancouver)137```1381. Smith JA, Jones BC. Title of article. Blood. 2024;143(5):567-578.139```140141### Nature (Author-Year)142```143Smith, J.A. & Jones, B.C. Title of article. Nature 620, 567–578 (2024).144```145146## Journal-Specific Requirements147148### Blood (ASH)149- Word limit: 4000 (full article)150- Figures: 7 max151- References: 60 max152- Structured abstract: 250 words153154### Nature155- Word limit: ~3000 (Article)156- Main text figures: 6-8157- Methods: no limit, separate section158- Extended Data for supplementary figures159160### Cell161- Word limit: 7000 (Article)162- STAR Methods format163- Graphical abstract required164165## HIPAA Compliance Reminders166167- No patient identifiers in any form168- Use Specimen IDs, not patient names/MRNs169- Aggregate data for small groups (n < 5)170- IRB approval statement required171- Data availability statement (GEO accession for sequencing)172173## Writing Style174175- Active voice preferred176- Past tense for results ("We found...")177- Present tense for established facts178- Avoid "interesting," "significant" (unless statistical)179- Be specific: "83.9-fold increase" not "marked increase"180181See `references/journal_templates.md` for specific formats.182See `references/statistical_tests.md` for test selection guide.183184185<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->